Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of metalloenzyme activity (GO:0048552) | 4.04800302 |
2 | Golgi transport vesicle coating (GO:0048200) | 3.70026967 |
3 | COPI coating of Golgi vesicle (GO:0048205) | 3.70026967 |
4 | angiotensin maturation (GO:0002003) | 3.52507333 |
5 | endothelium development (GO:0003158) | 3.51494986 |
6 | barbed-end actin filament capping (GO:0051016) | 3.44852927 |
7 | NADH metabolic process (GO:0006734) | 3.36775496 |
8 | pinocytosis (GO:0006907) | 3.36108275 |
9 | peptide catabolic process (GO:0043171) | 3.33846941 |
10 | fibril organization (GO:0097435) | 3.27250938 |
11 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.24819351 |
12 | protein maturation by protein folding (GO:0022417) | 3.17875505 |
13 | extracellular fibril organization (GO:0043206) | 3.16842310 |
14 | cyclooxygenase pathway (GO:0019371) | 3.15100024 |
15 | glycosphingolipid catabolic process (GO:0046479) | 3.08435754 |
16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.03307947 |
17 | glycolipid catabolic process (GO:0019377) | 2.99362512 |
18 | response to thyroid hormone (GO:0097066) | 2.96044004 |
19 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.92419234 |
20 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.86700448 |
21 | neutrophil activation involved in immune response (GO:0002283) | 2.86491898 |
22 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.84642998 |
23 | adhesion of symbiont to host cell (GO:0044650) | 2.84447846 |
24 | virion attachment to host cell (GO:0019062) | 2.84447846 |
25 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.83133251 |
26 | thrombin receptor signaling pathway (GO:0070493) | 2.79633909 |
27 | protein retention in ER lumen (GO:0006621) | 2.79276924 |
28 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.78521177 |
29 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.73874601 |
30 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.71035891 |
31 | adhesion of symbiont to host (GO:0044406) | 2.67330126 |
32 | hydrogen peroxide catabolic process (GO:0042744) | 2.63227309 |
33 | pentose-phosphate shunt (GO:0006098) | 2.61971673 |
34 | renal filtration (GO:0097205) | 2.51600154 |
35 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.51098135 |
36 | angiogenesis involved in wound healing (GO:0060055) | 2.50713055 |
37 | hyaluronan catabolic process (GO:0030214) | 2.48553315 |
38 | ceramide catabolic process (GO:0046514) | 2.46999421 |
39 | glucose catabolic process (GO:0006007) | 2.46765704 |
40 | glomerular filtration (GO:0003094) | 2.45723762 |
41 | autophagic vacuole fusion (GO:0000046) | 2.45696583 |
42 | fructose metabolic process (GO:0006000) | 2.44479220 |
43 | L-ascorbic acid metabolic process (GO:0019852) | 2.43549034 |
44 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.39811496 |
45 | keratan sulfate catabolic process (GO:0042340) | 2.37072645 |
46 | oxaloacetate metabolic process (GO:0006107) | 2.36710323 |
47 | oligosaccharide catabolic process (GO:0009313) | 2.36356752 |
48 | definitive hemopoiesis (GO:0060216) | 2.30225238 |
49 | positive regulation of pseudopodium assembly (GO:0031274) | 2.28730576 |
50 | GDP-mannose metabolic process (GO:0019673) | 2.27144312 |
51 | transcytosis (GO:0045056) | 2.26299754 |
52 | response to interferon-beta (GO:0035456) | 2.25632643 |
53 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.25449312 |
54 | response to peptidoglycan (GO:0032494) | 2.25357392 |
55 | UV protection (GO:0009650) | 2.24808081 |
56 | NADPH regeneration (GO:0006740) | 2.24751894 |
57 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.24527721 |
58 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.24397443 |
59 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.23818270 |
60 | negative regulation of humoral immune response (GO:0002921) | 2.23345452 |
61 | apoptotic cell clearance (GO:0043277) | 2.21852202 |
62 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.21708793 |
63 | regulation of superoxide anion generation (GO:0032928) | 2.21672381 |
64 | xenobiotic catabolic process (GO:0042178) | 2.21615345 |
65 | glycoside metabolic process (GO:0016137) | 2.21152783 |
66 | glutathione biosynthetic process (GO:0006750) | 2.20344215 |
67 | regulation of necrotic cell death (GO:0010939) | 2.19886640 |
68 | mature B cell differentiation involved in immune response (GO:0002313) | 2.18939550 |
69 | regulation of cellular extravasation (GO:0002691) | 2.17814459 |
70 | proline biosynthetic process (GO:0006561) | 2.16271321 |
71 | glutathione derivative biosynthetic process (GO:1901687) | 2.16261232 |
72 | glutathione derivative metabolic process (GO:1901685) | 2.16261232 |
73 | phagocytosis, engulfment (GO:0006911) | 2.15299806 |
74 | peptidyl-proline hydroxylation (GO:0019511) | 2.15122508 |
75 | hydrogen peroxide metabolic process (GO:0042743) | 2.14469736 |
76 | negative regulation of complement activation (GO:0045916) | 2.13817349 |
77 | cell volume homeostasis (GO:0006884) | 2.13147364 |
78 | regulation of pseudopodium assembly (GO:0031272) | 2.12362047 |
79 | immunoglobulin mediated immune response (GO:0016064) | 2.12253560 |
80 | positive regulation of receptor recycling (GO:0001921) | 2.11588949 |
81 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.11039570 |
82 | tricarboxylic acid metabolic process (GO:0072350) | 2.10920257 |
83 | sphingolipid catabolic process (GO:0030149) | 2.10069876 |
84 | ethanol oxidation (GO:0006069) | 2.09237428 |
85 | actin filament depolymerization (GO:0030042) | 2.08988112 |
86 | membrane lipid catabolic process (GO:0046466) | 2.07903292 |
87 | positive regulation of odontogenesis (GO:0042482) | 2.07785746 |
88 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.07647257 |
89 | regulation of extracellular matrix disassembly (GO:0010715) | 2.07579021 |
90 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.06185741 |
91 | hypotonic response (GO:0006971) | 2.05518957 |
92 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 2.05087888 |
93 | cellular response to cadmium ion (GO:0071276) | 2.04630200 |
94 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.04565501 |
95 | glutathione metabolic process (GO:0006749) | 2.04488940 |
96 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.04352701 |
97 | ethanol metabolic process (GO:0006067) | 2.04281796 |
98 | arachidonic acid metabolic process (GO:0019369) | 2.04129251 |
99 | membrane invagination (GO:0010324) | 2.03797706 |
100 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.03448369 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.23009451 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.20885155 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.86291558 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72902445 |
5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.70030159 |
6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.57681447 |
7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.43884470 |
8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.30320581 |
9 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.13668862 |
10 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13044665 |
11 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.09607029 |
12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98902418 |
13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.96795861 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96287913 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95449253 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92869141 |
17 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.92257519 |
18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89816907 |
19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73889073 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73870506 |
21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.73096376 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72435141 |
23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69018829 |
24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.68900675 |
25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.62211766 |
26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.59183995 |
27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57150667 |
28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56595946 |
29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52214335 |
30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52116469 |
31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.50078799 |
32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49503422 |
33 | GATA1_19941826_ChIP-Seq_K562_Human | 1.49255919 |
34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47548314 |
35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.47201522 |
36 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47031563 |
37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46574254 |
38 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46270829 |
39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44910244 |
40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44324565 |
41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43891718 |
42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.43603158 |
43 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42740736 |
44 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39685205 |
45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38224768 |
46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36979894 |
47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36862078 |
48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36214297 |
49 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.36210135 |
50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35670573 |
51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.34331227 |
52 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.33992471 |
53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30726737 |
54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29974804 |
55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.29731815 |
56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25378744 |
57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24186399 |
58 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24121038 |
59 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20284350 |
60 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20277565 |
61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20260473 |
62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20068823 |
63 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.19904655 |
64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18864559 |
65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18844772 |
66 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.18779230 |
67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18119291 |
68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18070758 |
69 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.17947728 |
70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17003458 |
71 | ATF3_27146783_Chip-Seq_COLON_Human | 1.16043231 |
72 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15386462 |
73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15021900 |
74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13715357 |
75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13243304 |
76 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12582001 |
77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12023265 |
78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11309081 |
79 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10319103 |
80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.10019721 |
81 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.08836684 |
82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.08443323 |
83 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08042436 |
84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06654342 |
85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06267167 |
86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05971868 |
87 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05351557 |
88 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05351557 |
89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04801693 |
90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04009188 |
91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03818968 |
92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02376014 |
93 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01397730 |
94 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01083808 |
95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00574114 |
96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00367837 |
97 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00367837 |
98 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00233655 |
99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00143408 |
100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99813920 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 3.42703111 |
2 | MP0009840_abnormal_foam_cell | 3.06083461 |
3 | MP0003191_abnormal_cellular_cholesterol | 2.69994315 |
4 | MP0003806_abnormal_nucleotide_metabolis | 2.61995328 |
5 | MP0008438_abnormal_cutaneous_collagen | 2.57440372 |
6 | MP0006054_spinal_hemorrhage | 2.45507793 |
7 | MP0005464_abnormal_platelet_physiology | 2.38163700 |
8 | MP0005165_increased_susceptibility_to | 2.26636618 |
9 | MP0005360_urolithiasis | 2.20905880 |
10 | MP0003075_altered_response_to | 1.99131256 |
11 | MP0002139_abnormal_hepatobiliary_system | 1.91885955 |
12 | MP0003279_aneurysm | 1.84812922 |
13 | MP0008004_abnormal_stomach_pH | 1.83866022 |
14 | MP0005451_abnormal_body_composition | 1.81594365 |
15 | MP0003436_decreased_susceptibility_to | 1.81166313 |
16 | MP0003724_increased_susceptibility_to | 1.80031185 |
17 | MP0000343_altered_response_to | 1.78829321 |
18 | MP0000465_gastrointestinal_hemorrhage | 1.69694466 |
19 | MP0010155_abnormal_intestine_physiology | 1.69073099 |
20 | MP0010368_abnormal_lymphatic_system | 1.68776102 |
21 | MP0003303_peritoneal_inflammation | 1.67504850 |
22 | MP0002148_abnormal_hypersensitivity_rea | 1.64144514 |
23 | MP0005365_abnormal_bile_salt | 1.58397894 |
24 | MP0004272_abnormal_basement_membrane | 1.52651763 |
25 | MP0003566_abnormal_cell_adhesion | 1.52125967 |
26 | MP0005166_decreased_susceptibility_to | 1.49064440 |
27 | MP0001533_abnormal_skeleton_physiology | 1.48028783 |
28 | MP0005397_hematopoietic_system_phenotyp | 1.46186926 |
29 | MP0001545_abnormal_hematopoietic_system | 1.46186926 |
30 | MP0003828_pulmonary_edema | 1.44060899 |
31 | MP0005023_abnormal_wound_healing | 1.43956739 |
32 | MP0003705_abnormal_hypodermis_morpholog | 1.43617372 |
33 | MP0009780_abnormal_chondrocyte_physiolo | 1.39142678 |
34 | MP0001835_abnormal_antigen_presentation | 1.38925748 |
35 | MP0005670_abnormal_white_adipose | 1.38718811 |
36 | MP0003172_abnormal_lysosome_physiology | 1.37313874 |
37 | MP0010234_abnormal_vibrissa_follicle | 1.36456683 |
38 | MP0006082_CNS_inflammation | 1.35510886 |
39 | MP0000013_abnormal_adipose_tissue | 1.32137940 |
40 | MP0003186_abnormal_redox_activity | 1.31497370 |
41 | MP0003950_abnormal_plasma_membrane | 1.28502154 |
42 | MP0002419_abnormal_innate_immunity | 1.27917666 |
43 | MP0002132_abnormal_respiratory_system | 1.23322192 |
44 | MP0008260_abnormal_autophagy | 1.22625822 |
45 | MP0004510_myositis | 1.22020198 |
46 | MP0009643_abnormal_urine_homeostasis | 1.21604576 |
47 | MP0005330_cardiomyopathy | 1.21091130 |
48 | MP0004858_abnormal_nervous_system | 1.20961586 |
49 | MP0000751_myopathy | 1.20830126 |
50 | MP0009278_abnormal_bone_marrow | 1.20672805 |
51 | MP0002877_abnormal_melanocyte_morpholog | 1.18750867 |
52 | MP0005025_abnormal_response_to | 1.16447980 |
53 | MP0006036_abnormal_mitochondrial_physio | 1.15404358 |
54 | MP0003300_gastrointestinal_ulcer | 1.14275120 |
55 | MP0009785_altered_susceptibility_to | 1.13389552 |
56 | MP0001666_abnormal_nutrient_absorption | 1.13064590 |
57 | MP0008469_abnormal_protein_level | 1.12033871 |
58 | MP0004782_abnormal_surfactant_physiolog | 1.08858864 |
59 | MP0000858_altered_metastatic_potential | 1.06711404 |
60 | MP0000681_abnormal_thyroid_gland | 1.06691345 |
61 | MP0004036_abnormal_muscle_relaxation | 1.05662558 |
62 | MP0008775_abnormal_heart_ventricle | 1.05324736 |
63 | MP0001958_emphysema | 1.04595952 |
64 | MP0005085_abnormal_gallbladder_physiolo | 1.03629259 |
65 | MP0000678_abnormal_parathyroid_gland | 1.02988344 |
66 | MP0004019_abnormal_vitamin_homeostasis | 1.02697377 |
67 | MP0005164_abnormal_response_to | 1.01787570 |
68 | MP0002998_abnormal_bone_remodeling | 1.00524617 |
69 | MP0001845_abnormal_inflammatory_respons | 0.99976156 |
70 | MP0005319_abnormal_enzyme/_coenzyme | 0.99945735 |
71 | MP0001873_stomach_inflammation | 0.99473398 |
72 | MP0001542_abnormal_bone_strength | 0.98232618 |
73 | MP0000249_abnormal_blood_vessel | 0.98190925 |
74 | MP0005083_abnormal_biliary_tract | 0.97314891 |
75 | MP0004084_abnormal_cardiac_muscle | 0.95306247 |
76 | MP0004147_increased_porphyrin_level | 0.93857953 |
77 | MP0004264_abnormal_extraembryonic_tissu | 0.93831890 |
78 | MP0001663_abnormal_digestive_system | 0.93543685 |
79 | MP0009764_decreased_sensitivity_to | 0.92902967 |
80 | MP0002896_abnormal_bone_mineralization | 0.92774238 |
81 | MP0010352_gastrointestinal_tract_polyps | 0.90876031 |
82 | MP0000604_amyloidosis | 0.89432863 |
83 | MP0003656_abnormal_erythrocyte_physiolo | 0.89220468 |
84 | MP0005332_abnormal_amino_acid | 0.87950364 |
85 | MP0005167_abnormal_blood-brain_barrier | 0.87149450 |
86 | MP0000747_muscle_weakness | 0.87092121 |
87 | MP0005390_skeleton_phenotype | 0.86706876 |
88 | MP0001853_heart_inflammation | 0.85854554 |
89 | MP0000003_abnormal_adipose_tissue | 0.84830345 |
90 | MP0003448_altered_tumor_morphology | 0.84155087 |
91 | MP0002118_abnormal_lipid_homeostasis | 0.83487074 |
92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83419591 |
93 | MP0001664_abnormal_digestion | 0.83313681 |
94 | MP0005375_adipose_tissue_phenotype | 0.83007338 |
95 | MP0008875_abnormal_xenobiotic_pharmacok | 0.81842255 |
96 | MP0004947_skin_inflammation | 0.81549411 |
97 | MP0005636_abnormal_mineral_homeostasis | 0.81515434 |
98 | MP0005275_abnormal_skin_tensile | 0.81292694 |
99 | MP0001756_abnormal_urination | 0.80875401 |
100 | MP0005666_abnormal_adipose_tissue | 0.80684762 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 3.95173001 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.87024124 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.87024124 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 3.87024124 |
5 | Petechiae (HP:0000967) | 3.36804955 |
6 | Dysostosis multiplex (HP:0000943) | 3.34428856 |
7 | Nuclear cataract (HP:0100018) | 3.18073984 |
8 | Distal lower limb muscle weakness (HP:0009053) | 3.03386252 |
9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98066018 |
10 | Vacuolated lymphocytes (HP:0001922) | 2.96167263 |
11 | Vertebral compression fractures (HP:0002953) | 2.88985249 |
12 | Purpura (HP:0000979) | 2.86550615 |
13 | Premature rupture of membranes (HP:0001788) | 2.82584990 |
14 | Loss of speech (HP:0002371) | 2.82510599 |
15 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.78910677 |
16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.78910677 |
17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.78910677 |
18 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.77772285 |
19 | Mucopolysacchariduria (HP:0008155) | 2.77772285 |
20 | Protrusio acetabuli (HP:0003179) | 2.76428667 |
21 | Asymmetric septal hypertrophy (HP:0001670) | 2.75805973 |
22 | Amyloidosis (HP:0011034) | 2.67818466 |
23 | Malnutrition (HP:0004395) | 2.66192762 |
24 | Abnormality of the nasal mucosa (HP:0000433) | 2.54372926 |
25 | Rhabdomyolysis (HP:0003201) | 2.46972950 |
26 | Hydroxyprolinuria (HP:0003080) | 2.46915448 |
27 | Abnormality of proline metabolism (HP:0010907) | 2.46915448 |
28 | Abnormality of complement system (HP:0005339) | 2.46448141 |
29 | Axonal loss (HP:0003447) | 2.42909260 |
30 | Glomerulonephritis (HP:0000099) | 2.39416299 |
31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.38655724 |
32 | Complement deficiency (HP:0004431) | 2.38239724 |
33 | Prolonged bleeding time (HP:0003010) | 2.33893342 |
34 | Increased cerebral lipofuscin (HP:0011813) | 2.30869739 |
35 | Exercise-induced myalgia (HP:0003738) | 2.29659933 |
36 | Myoglobinuria (HP:0002913) | 2.21597185 |
37 | Hypertensive crisis (HP:0100735) | 2.19778869 |
38 | Hepatosplenomegaly (HP:0001433) | 2.14371080 |
39 | Osteolytic defects of the hand bones (HP:0009699) | 2.10508725 |
40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10508725 |
41 | Distal upper limb amyotrophy (HP:0007149) | 2.05390019 |
42 | Upper limb amyotrophy (HP:0009129) | 2.05390019 |
43 | J-shaped sella turcica (HP:0002680) | 2.03551547 |
44 | Cervical subluxation (HP:0003308) | 2.02166862 |
45 | Polycythemia (HP:0001901) | 2.01295296 |
46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.01194467 |
47 | Increased serum ferritin (HP:0003281) | 1.99753108 |
48 | Interstitial pulmonary disease (HP:0006530) | 1.98549555 |
49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98221794 |
50 | Increased connective tissue (HP:0009025) | 1.96202866 |
51 | Abnormality of macrophages (HP:0004311) | 1.96169971 |
52 | Epistaxis (HP:0000421) | 1.93864077 |
53 | Hemorrhage of the eye (HP:0011885) | 1.92182726 |
54 | Myocardial infarction (HP:0001658) | 1.91432543 |
55 | Atelectasis (HP:0100750) | 1.91152405 |
56 | Prolonged neonatal jaundice (HP:0006579) | 1.90922661 |
57 | Joint stiffness (HP:0001387) | 1.90028528 |
58 | Nasal polyposis (HP:0100582) | 1.89589685 |
59 | Aortic aneurysm (HP:0004942) | 1.86645396 |
60 | Growth hormone excess (HP:0000845) | 1.85817307 |
61 | Impaired platelet aggregation (HP:0003540) | 1.85498707 |
62 | Abnormal platelet function (HP:0011869) | 1.85498707 |
63 | Fat malabsorption (HP:0002630) | 1.84341176 |
64 | Bulbar palsy (HP:0001283) | 1.83750118 |
65 | Ileus (HP:0002595) | 1.83575162 |
66 | Progressive neurologic deterioration (HP:0002344) | 1.82943806 |
67 | Cholecystitis (HP:0001082) | 1.82744117 |
68 | Abnormal gallbladder physiology (HP:0012438) | 1.82744117 |
69 | Cerebral aneurysm (HP:0004944) | 1.81580271 |
70 | Ragged-red muscle fibers (HP:0003200) | 1.81471720 |
71 | Steatorrhea (HP:0002570) | 1.81234378 |
72 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80981121 |
73 | Vascular calcification (HP:0004934) | 1.80401204 |
74 | Abnormality of iron homeostasis (HP:0011031) | 1.79796960 |
75 | Cardiovascular calcification (HP:0011915) | 1.77631636 |
76 | Increased CSF protein (HP:0002922) | 1.77615621 |
77 | Myopathic facies (HP:0002058) | 1.76098224 |
78 | Xanthomatosis (HP:0000991) | 1.75992704 |
79 | Type 1 muscle fiber predominance (HP:0003803) | 1.74786965 |
80 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.74371454 |
81 | Increased variability in muscle fiber diameter (HP:0003557) | 1.74349076 |
82 | Polygenic inheritance (HP:0010982) | 1.74081239 |
83 | Hyperammonemia (HP:0001987) | 1.73729118 |
84 | Nemaline bodies (HP:0003798) | 1.71979014 |
85 | Stridor (HP:0010307) | 1.71877349 |
86 | Recurrent abscess formation (HP:0002722) | 1.71841694 |
87 | Fragile skin (HP:0001030) | 1.70159186 |
88 | Menorrhagia (HP:0000132) | 1.69394022 |
89 | Hand muscle atrophy (HP:0009130) | 1.68633760 |
90 | Glucose intolerance (HP:0000833) | 1.68073446 |
91 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.66944837 |
92 | Stroke (HP:0001297) | 1.65838122 |
93 | Spinal rigidity (HP:0003306) | 1.64626920 |
94 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.64292594 |
95 | Nausea (HP:0002018) | 1.64227450 |
96 | Right ventricular cardiomyopathy (HP:0011663) | 1.63195578 |
97 | Nephritis (HP:0000123) | 1.63017773 |
98 | Thrombocytosis (HP:0001894) | 1.62770866 |
99 | Hyperparathyroidism (HP:0000843) | 1.62598172 |
100 | Distal lower limb amyotrophy (HP:0008944) | 1.62307374 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.80887091 |
2 | NME2 | 3.74859469 |
3 | MYLK | 2.76693199 |
4 | TESK1 | 2.54089148 |
5 | IRAK3 | 2.52262780 |
6 | MST1R | 2.50863297 |
7 | EPHA2 | 2.28602515 |
8 | PDK2 | 2.15632484 |
9 | MAP2K3 | 2.05894396 |
10 | RIPK1 | 2.03979358 |
11 | TGFBR2 | 1.95163041 |
12 | MST4 | 1.90414918 |
13 | TBK1 | 1.87324200 |
14 | TESK2 | 1.85953065 |
15 | SCYL2 | 1.82572724 |
16 | MAPKAPK3 | 1.79257096 |
17 | MAP3K3 | 1.65773365 |
18 | LIMK1 | 1.53833877 |
19 | TIE1 | 1.51220417 |
20 | PRKG2 | 1.46324539 |
21 | ZAP70 | 1.44239380 |
22 | ABL2 | 1.43953079 |
23 | TYK2 | 1.42566662 |
24 | MAP3K12 | 1.42484722 |
25 | PIM2 | 1.38693615 |
26 | PAK4 | 1.38202825 |
27 | LMTK2 | 1.35512162 |
28 | KDR | 1.31222828 |
29 | KIT | 1.27752732 |
30 | FER | 1.23994554 |
31 | TRPM7 | 1.22116890 |
32 | LRRK2 | 1.21680035 |
33 | TRIB3 | 1.21111590 |
34 | TTN | 1.19901524 |
35 | PBK | 1.19306467 |
36 | BCKDK | 1.17970975 |
37 | ILK | 1.17555428 |
38 | PTK2 | 1.11226994 |
39 | FLT3 | 1.10447230 |
40 | MAP3K11 | 1.09396486 |
41 | JAK3 | 1.03585260 |
42 | MAP3K1 | 1.01554849 |
43 | MET | 1.01250891 |
44 | MAP2K6 | 1.00176487 |
45 | MAP3K6 | 1.00097899 |
46 | EPHB1 | 0.98390080 |
47 | DDR2 | 0.97729732 |
48 | TAOK2 | 0.93187800 |
49 | RIPK4 | 0.92847375 |
50 | MAP3K2 | 0.91579181 |
51 | BMX | 0.91279985 |
52 | BMPR2 | 0.90948273 |
53 | ACVR1B | 0.90170000 |
54 | MAP3K14 | 0.89319449 |
55 | EPHB2 | 0.87824761 |
56 | PDPK1 | 0.86777237 |
57 | EIF2AK1 | 0.85309845 |
58 | PHKG1 | 0.82575674 |
59 | PHKG2 | 0.82575674 |
60 | VRK2 | 0.79569175 |
61 | ERBB4 | 0.74525669 |
62 | PRKD2 | 0.74087571 |
63 | PTK2B | 0.71933204 |
64 | SMG1 | 0.70322756 |
65 | STK10 | 0.68289549 |
66 | PTK6 | 0.66280292 |
67 | FES | 0.62597704 |
68 | ARAF | 0.62505658 |
69 | CDC42BPA | 0.60498516 |
70 | TEC | 0.59440779 |
71 | PIK3CG | 0.58888260 |
72 | DAPK3 | 0.57984416 |
73 | DAPK1 | 0.57884910 |
74 | GRK7 | 0.57837788 |
75 | TNK2 | 0.56934593 |
76 | CSF1R | 0.56641039 |
77 | HIPK2 | 0.55943882 |
78 | PAK1 | 0.55214193 |
79 | CSK | 0.53839324 |
80 | MATK | 0.53445393 |
81 | PRPF4B | 0.52765046 |
82 | MAP2K2 | 0.51471876 |
83 | MOS | 0.51108933 |
84 | PRKAA2 | 0.49720017 |
85 | BLK | 0.48277775 |
86 | PRKD1 | 0.47743027 |
87 | CAMK2G | 0.47598622 |
88 | STK16 | 0.47302411 |
89 | PAK2 | 0.46714767 |
90 | IKBKB | 0.44734126 |
91 | MAP3K8 | 0.44617922 |
92 | PKN2 | 0.44052326 |
93 | GSK3A | 0.43838480 |
94 | BTK | 0.43467626 |
95 | MAP2K1 | 0.42436525 |
96 | PDGFRA | 0.41139812 |
97 | CAMK2D | 0.40677824 |
98 | NEK9 | 0.40096383 |
99 | MAPK11 | 0.39402792 |
100 | JAK1 | 0.38449823 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.97477736 |
2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.79121417 |
3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.28031664 |
4 | Lysosome_Homo sapiens_hsa04142 | 2.24666937 |
5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.22808724 |
6 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.19072076 |
7 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.18718874 |
8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.15176407 |
9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.12467239 |
10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.03764839 |
11 | Galactose metabolism_Homo sapiens_hsa00052 | 2.02298349 |
12 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.93032482 |
13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.91924102 |
14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.79475968 |
15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.66328304 |
16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.65795626 |
17 | Mineral absorption_Homo sapiens_hsa04978 | 1.62227685 |
18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57952872 |
19 | Asthma_Homo sapiens_hsa05310 | 1.56591061 |
20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53441983 |
21 | Pertussis_Homo sapiens_hsa05133 | 1.40175195 |
22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.38375439 |
23 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.30758705 |
24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.30726573 |
25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.29943284 |
26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27420530 |
27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.25065183 |
28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.22525554 |
29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22193963 |
30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.18511318 |
31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.16684454 |
32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15536428 |
33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13909729 |
34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.13483257 |
35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13254378 |
36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11655426 |
37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11510978 |
38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07433260 |
39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.05136237 |
40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05075159 |
41 | Allograft rejection_Homo sapiens_hsa05330 | 1.03282603 |
42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01635283 |
43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97427456 |
44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.96014074 |
45 | Platelet activation_Homo sapiens_hsa04611 | 0.94076424 |
46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.92935099 |
47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92593065 |
48 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88075183 |
49 | Salmonella infection_Homo sapiens_hsa05132 | 0.87172140 |
50 | Peroxisome_Homo sapiens_hsa04146 | 0.86870220 |
51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86689587 |
52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84572603 |
53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83954129 |
54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83917098 |
55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83749865 |
56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83539023 |
57 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83022868 |
58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80922289 |
59 | * Amoebiasis_Homo sapiens_hsa05146 | 0.80688654 |
60 | Shigellosis_Homo sapiens_hsa05131 | 0.79518632 |
61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79133517 |
62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78939907 |
63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78314761 |
64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76386788 |
65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.76020574 |
66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74746004 |
67 | Tuberculosis_Homo sapiens_hsa05152 | 0.74043307 |
68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72435192 |
69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71481584 |
70 | Phagosome_Homo sapiens_hsa04145 | 0.71457747 |
71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70232895 |
72 | Legionellosis_Homo sapiens_hsa05134 | 0.69530865 |
73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68789978 |
74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67801630 |
75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62840944 |
76 | Insulin resistance_Homo sapiens_hsa04931 | 0.62794758 |
77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62369864 |
78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61526839 |
79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58300928 |
80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57533755 |
81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54945057 |
82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53205556 |
83 | Hepatitis C_Homo sapiens_hsa05160 | 0.53202638 |
84 | Influenza A_Homo sapiens_hsa05164 | 0.52919637 |
85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52115039 |
86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49773291 |
87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49584356 |
88 | Prion diseases_Homo sapiens_hsa05020 | 0.49420780 |
89 | Malaria_Homo sapiens_hsa05144 | 0.48436725 |
90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47826771 |
91 | Endocytosis_Homo sapiens_hsa04144 | 0.47750706 |
92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47194918 |
93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45849591 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44877441 |
95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42816208 |
96 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40597436 |
97 | Focal adhesion_Homo sapiens_hsa04510 | 0.40464402 |
98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40314298 |
99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39843141 |
100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39380263 |